Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-16

Clinical Trial Update: Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of ketoacid supplementation in patients with stage III to IV renal failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ketoacid supplementation

Snippet

Sponsor: University of Chile | Conditions: Renal Failure | Phase 3 | Status: COMPLETED